Lv12
20 积分 2024-10-31 加入
Small Molecule Inhibitors Targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for Cancer Immunotherapy (2020-2024)
7小时前
已完结
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
7小时前
已完结
The role of hypoxia‐inducible factor 1 in tumor immune evasion
22小时前
已完结
[Expression and Significance of PD-1/PD-L1 in MDS Blast Cells, T Lymphocyte Cell Subsets and Treg Cells]
5天前
已完结
Natural killer cells: unlocking new treatments for bladder cancer
6天前
已完结
New expression of PD-L1 on activated CD4+ T cells opens up new opportunities for cell interactions and signaling
6天前
已完结
Immunosuppressive B cells expressing PD-1/PD-L1 in solid tumors: a mini review
6天前
已完结
Revisiting PD-1/PD-L pathway in T and B cell response: Beyond immunosuppression
6天前
已完结
The therapeutic impact of programmed death – 1 in the treatment of colorectal cancer
6天前
已完结
The emerging roles of PD-L1 subcellular localization in tumor immune evasion
7天前
已完结
皖公网安备34019202002308
